Top Page
Tiande Chemical Holdings Limited
(0609)
Tiande Chemical Holdings Limited (0609) vs. iShares MSCI Hong Kong ETF (EWH)
Tiande Chemical Holdings Limited Business Overview & Revenue Model
Tiande Chemical Holdings Limited Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 1.87B | 2.08B | 3.52B | 2.58B | 1.36B |
| Gross Profit | 200.07M | 227.48M | 438.84M | 1.48B | 777.87M | 181.13M |
| EBITDA | 160.26M | 154.21M | 436.44M | 1.40B | 678.07M | 144.80M |
| Net Income | 59.68M | 66.88M | 211.07M | 870.92M | 379.65M | 94.82M |
Balance Sheet | ||||||
| Total Assets | 3.18B | 3.08B | 2.92B | 2.96B | 2.32B | 1.92B |
| Cash, Cash Equivalents and Short-Term Investments | 848.92M | 851.55M | 615.06M | 492.13M | 226.35M | 125.31M |
| Total Debt | 354.19M | 220.13M | 0.00 | 45.72M | 154.76M | 215.51M |
| Total Liabilities | 678.38M | 569.51M | 364.24M | 456.06M | 561.92M | 536.01M |
| Stockholders Equity | 2.43B | 2.42B | 2.44B | 2.41B | 1.75B | 1.39B |
Cash Flow | ||||||
| Free Cash Flow | 113.33M | 195.67M | 330.76M | 592.74M | 60.86M | -45.32M |
| Operating Cash Flow | 293.93M | 395.43M | 649.23M | 854.84M | 274.33M | 170.53M |
| Investing Cash Flow | 199.29M | -219.65M | -543.42M | -469.45M | -84.39M | -180.60M |
| Financing Cash Flow | 3.37M | 6.65M | -232.55M | -337.13M | -88.77M | -29.44M |
Tiande Chemical Holdings Limited Technical Analysis
Tiande Chemical Holdings Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$4.47B | 7.86 | 9.36% | 6.70% | -3.73% | 6.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.30B | 20.16 | 2.46% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.18B | 16.45 | 3.61% | 2.20% | -8.51% | -68.34% | |
56 Neutral | HK$4.20B | 5.57 | 13.87% | ― | 9.20% | 213.87% | |
46 Neutral | HK$224.90M | -0.32 | -112.79% | ― | -22.72% | -212.73% |
Tiande Chemical Holdings Limited Corporate Events
Tiande Chemical Holdings Limited has announced the composition of its board of directors with effect from 1 January 2026, naming Liu Yang as chairman alongside executive directors Chen Xiaohua and Dou Aobo, non-executive director Wang Zijiang, and independent non-executive directors Leung Kam Wan, Liu Chenguang and Shan Honghong. The company has also confirmed the membership and leadership of its four key board committees—Audit, Remuneration, Nomination, and Safety and Environmental Protection—clarifying oversight responsibilities among directors and reinforcing its corporate governance and risk management framework, particularly in financial control, pay policies, board succession, and environmental and safety matters.
The most recent analyst rating on (HK:0609) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Tiande Chemical Holdings Limited stock, see the HK:0609 Stock Forecast page.
Tiande Chemical Holdings Limited has agreed to acquire the remaining 49% equity interest in a non-wholly owned subsidiary from an existing substantial shareholder for RMB88 million, turning the target into an indirect wholly owned subsidiary. The consideration will be settled mainly by offsetting debt owed by the vendor to the purchaser, with a small remaining balance to be paid in cash, and the deal is classified as a discloseable and connected transaction under Hong Kong’s Listing Rules, though exempt from shareholder approval; directors state the terms are fair and in the interests of the company and its shareholders, indicating a move to consolidate control and streamline the group’s corporate structure.
Tiande Chemical Holdings Limited has revised and approved updated terms of reference for its audit committee, effective 23 December 2025, formalising requirements that the committee comprise at least three members drawn from independent non-executive directors, including at least one with professional accounting or financial management expertise, and be chaired by an independent non-executive director. The revised framework strengthens the company’s corporate governance by detailing membership criteria, meeting frequency and notice procedures, quorum rules, minute-keeping, and requirements for annual meetings with external auditors, which collectively are designed to enhance oversight of financial reporting and internal control for the benefit of shareholders and other stakeholders.
Tiande Chemical Holdings Limited has revised and approved updated terms of reference for its remuneration committee, effective 23 December 2025, setting out the committee’s composition, roles and operating procedures. The new terms formalize that a majority of members, including the committee chair, must be independent non-executive directors, define meeting frequency, notice requirements, quorum, minute-keeping and voting arrangements, and allow participation by teleconference, underscoring the company’s efforts to strengthen corporate governance and oversight of directors’ and senior management’s remuneration.
Tiande Chemical Holdings has appointed independent non-executive director Ms. Shan Honghong as a member of its nomination committee, effective 1 January 2026, expanding the committee to four members. The board stated that this move is intended to improve gender diversity within the nomination committee and strengthen overall corporate governance practices in line with Hong Kong’s Corporate Governance Code, underscoring the company’s efforts to enhance regulatory compliance and board oversight structures.
Tiande Chemical Holdings Limited has announced board changes effective 1 January 2026, with co‑founder and long‑serving executive director Wang Zijiang to be re‑designated as a non‑executive director so he can devote more time to other affairs. Wang, who has over 29 years of experience in the chemical industry and holds a significant stake in the company, will remain on the board under a new three‑year service agreement, signaling continuity of strategic oversight despite his shift away from day‑to‑day management. At the same time, deputy general manager Dou Aobo will be promoted to executive director, reflecting the company’s ongoing management succession and the elevation of internal operational leadership as Tiande Chemical seeks to maintain stability and support its longer‑term development.